229 related articles for article (PubMed ID: 16778208)
1. Notch3 gene amplification in ovarian cancer.
Park JT; Li M; Nakayama K; Mao TL; Davidson B; Zhang Z; Kurman RJ; Eberhart CG; Shih IeM; Wang TL
Cancer Res; 2006 Jun; 66(12):6312-8. PubMed ID: 16778208
[TBL] [Abstract][Full Text] [Related]
2. Amplicon profiles in ovarian serous carcinomas.
Nakayama K; Nakayama N; Jinawath N; Salani R; Kurman RJ; Shih IeM; Wang TL
Int J Cancer; 2007 Jun; 120(12):2613-7. PubMed ID: 17351921
[TBL] [Abstract][Full Text] [Related]
3. Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes.
Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Iida K; Otsuki Y; Kobayashi H; Nakayama S; Miyazaki K
Gynecol Oncol; 2010 Jun; 117(3):409-16. PubMed ID: 20359736
[TBL] [Abstract][Full Text] [Related]
4. Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer.
Rahman MT; Nakayama K; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Nakayama S; Otsuki Y; Miyazaki K
Am J Clin Pathol; 2012 Oct; 138(4):535-44. PubMed ID: 23010708
[TBL] [Abstract][Full Text] [Related]
5. Identification of Pbx1, a potential oncogene, as a Notch3 target gene in ovarian cancer.
Park JT; Shih IeM; Wang TL
Cancer Res; 2008 Nov; 68(21):8852-60. PubMed ID: 18974129
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of genes in regions commonly amplified in high-grade serous and endometrioid ovarian cancer.
Davis SJ; Sheppard KE; Pearson RB; Campbell IG; Gorringe KL; Simpson KJ
Clin Cancer Res; 2013 Mar; 19(6):1411-21. PubMed ID: 23362323
[TBL] [Abstract][Full Text] [Related]
7. Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma.
Shih IeM; Nakayama K; Wu G; Nakayama N; Zhang J; Wang TL
Mod Pathol; 2011 May; 24(5):638-45. PubMed ID: 21240255
[TBL] [Abstract][Full Text] [Related]
8. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
Tsuda H; Birrer MJ; Ito YM; Ohashi Y; Lin M; Lee C; Wong WH; Rao PH; Lau CC; Berkowitz RS; Wong KK; Mok SC
Cancer Genet Cytogenet; 2004 Dec; 155(2):97-107. PubMed ID: 15571795
[TBL] [Abstract][Full Text] [Related]
9. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.
Brown LA; Irving J; Parker R; Kim H; Press JZ; Longacre TA; Chia S; Magliocco A; Makretsov N; Gilks B; Pollack J; Huntsman D
Gynecol Oncol; 2006 Feb; 100(2):264-70. PubMed ID: 16236351
[TBL] [Abstract][Full Text] [Related]
10. Defining NOTCH3 target genes in ovarian cancer.
Chen X; Thiaville MM; Chen L; Stoeck A; Xuan J; Gao M; Shih IeM; Wang TL
Cancer Res; 2012 May; 72(9):2294-303. PubMed ID: 22396495
[TBL] [Abstract][Full Text] [Related]
11. Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas.
Birrer MJ; Johnson ME; Hao K; Wong KK; Park DC; Bell A; Welch WR; Berkowitz RS; Mok SC
J Clin Oncol; 2007 Jun; 25(16):2281-7. PubMed ID: 17538174
[TBL] [Abstract][Full Text] [Related]
12. Notch3 pathway alterations in ovarian cancer.
Hu W; Liu T; Ivan C; Sun Y; Huang J; Mangala LS; Miyake T; Dalton HJ; Pradeep S; Rupaimoole R; Previs RA; Han HD; Bottsford-Miller J; Zand B; Kang Y; Pecot CV; Nick AM; Wu SY; Lee JS; Sehgal V; Ram P; Liu J; Tucker SL; Lopez-Berestein G; Baggerly KA; Coleman RL; Sood AK
Cancer Res; 2014 Jun; 74(12):3282-93. PubMed ID: 24743243
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes.
Noske A; Henricksen LA; LaFleur B; Zimmermann AK; Tubbs A; Singh S; Storz M; Fink D; Moch H
Exp Mol Pathol; 2015 Feb; 98(1):47-54. PubMed ID: 25527175
[TBL] [Abstract][Full Text] [Related]
14. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.
Yamaguchi N; Oyama T; Ito E; Satoh H; Azuma S; Hayashi M; Shimizu K; Honma R; Yanagisawa Y; Nishikawa A; Kawamura M; Imai J; Ohwada S; Tatsuta K; Inoue J; Semba K; Watanabe S
Cancer Res; 2008 Mar; 68(6):1881-8. PubMed ID: 18339869
[TBL] [Abstract][Full Text] [Related]
15. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB
Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414
[TBL] [Abstract][Full Text] [Related]
16. Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer.
Jung JG; Stoeck A; Guan B; Wu RC; Zhu H; Blackshaw S; Shih IeM; Wang TL
PLoS Genet; 2014 Oct; 10(10):e1004751. PubMed ID: 25356737
[TBL] [Abstract][Full Text] [Related]
17. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
[TBL] [Abstract][Full Text] [Related]
18. Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin.
Park JT; Chen X; Tropè CG; Davidson B; Shih IeM; Wang TL
Am J Pathol; 2010 Sep; 177(3):1087-94. PubMed ID: 20671266
[TBL] [Abstract][Full Text] [Related]
19. Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma.
Mao TL; Hsu CY; Yen MJ; Gilks B; Sheu JJ; Gabrielson E; Vang R; Cope L; Kurman RJ; Wang TL; Shih IeM
Hum Pathol; 2006 Sep; 37(9):1169-75. PubMed ID: 16938522
[TBL] [Abstract][Full Text] [Related]
20. Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma.
Shih IeM; Sheu JJ; Santillan A; Nakayama K; Yen MJ; Bristow RE; Vang R; Parmigiani G; Kurman RJ; Trope CG; Davidson B; Wang TL
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):14004-9. PubMed ID: 16172393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
